Effect of imiquimod on partial-thickness burns

Area of Science:

• Dermatology
• Wound Healing
• Immunology

Background:

• Burns cause significant morbidity due to fibroblast proliferation and contracture.
• Imiquimod (IMQ), an immune modifier, suppresses fibroblast proliferation and is used for various skin conditions.
• Previous studies explored IMQ for hypertrophic scars and keloids, but its effect on cutaneous burns remained unevaluated.

Purpose of the Study:

• To evaluate the efficacy of topical imiquimod (IMQ) in treating partial-thickness cutaneous burns in a rat model.
• To assess IMQ's impact on wound healing, clinical appearance, scarring, and collagen deposition.

Main Methods:

• Partial-thickness burns were induced in Wistar rats, with one side treated with saline and the other with 5% IMQ cream.
• Wound appearance was assessed using clinical and visual analog scales, and scars were measured by digital planimetry.
• Histological analysis included hematoxylin-eosin staining for conventional histology and Sirius Red staining for collagen morphometry.

Main Results:

• The IMQ group exhibited delayed reepithelialization and accentuated inflammation compared to the saline group.
• While visual scores were higher in the saline group on post-burn day 21, IMQ treatment decreased fibrosis.
• Significant differences in type-I and type-III collagen deposition and their ratio were observed between the IMQ and saline groups.

Conclusions:

• Short-term topical IMQ treatment did not improve the clinical appearance or scarring of partial-thickness burns in rats.
• IMQ treatment resulted in decreased fibrosis and altered collagen deposition, suggesting a complex effect on wound healing.
• Further research is needed to understand the precise mechanisms and potential therapeutic applications of IMQ in burn management.